The map provides a state-by-state breakdown of the nation’s hepatitis C epidemic. Approximately 3.9 million Americans carry hepatitis C antibodies, which are indicative of either past or current infections.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
“HepVu empowers hepatitis advocates, state health departments, and policy makers to use data-driven tools to push for better programs to provide testing, care and treatment for HCV for people in need of these services across the nation,” said Patrick Sullivan, PhD, professor of epidemiology at Emory and principal scientist for HepVu. “By mapping the epidemic, HepVu helps us understand which states are most impacted by Hepatitis C, and where we need to focus our screening and treatment resources.”
To learn more about hepatitis C, click here.
More articles on infection control:
Chicago health department offers families free whooping cough vaccine
Researchers create synthetic mucus to ward off infections
Strep strain shows newly detected signs of antibiotic resistance, study shows
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.